Dietary Omega-3 Supplements Improve ADHD Symptoms

This article originally appeared here.
Share this content:
Dietary Omega-3 Supplements Improve ADHD Symptoms
Dietary Omega-3 Supplements Improve ADHD Symptoms

FRIDAY, March 20, 2015 (HealthDay News) -- Dietary omega-3 fatty acid supplementation is associated with improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms for children with ADHD and typically developing children, according to a study published online March 19 in Neuropsychopharmacology.

Dienke J. Bos, from the University Medical Center Utrecht in the Netherlands, and colleagues examined the effects of dietary omega-3 fatty acid supplementation on ADHD symptoms and cognitive control in 40 boys with ADHD (aged 8 to 14 years) and 39 matched controls. Participants consumed 10 g margarine daily, enriched with omega-3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) or placebo.

The researchers found that parent-rated attention improved with EPA/DHA supplementation among children with ADHD and typically developing children. For children receiving EPA/DHA supplements versus placebo, phospholipid DHA-level at follow-up was higher. EPA/DHA supplementation had no impact on cognitive control or on functional magnetic resonance imaging measures of brain activity.

"This study shows that dietary supplementation with omega-3 fatty acids reduces symptoms of ADHD, both for individuals with ADHD and typically developing children," the authors write.

The study was funded by Unilever Research & Development

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »